Commonwealth Bank of Australia’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Commonwealth Bank of Australia’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,300	Closed	-$111K	–	1012
2019 Q2	$111K	Buy	1,300 +500	+63%	+$49.5K	﹤0.01%	935
2019 Q1	$86K	Hold	800	–	–	﹤0.01%	941
2018 Q4	$67K	Hold	800	–	–	﹤0.01%	952
2018 Q3	$78K	Buy	+800	New	+$86.6K	﹤0.01%	987
2017 Q4	–	Sell	-100	Closed	-$11K	–	874
2017 Q3	$11K	Sell	100 -700	-88%	-$76.2K	﹤0.01%	763
2017 Q2	$89K	Buy	800 +200	+33%	+$22.6K	﹤0.01%	726
2017 Q1	$70K	Hold	600	–	–	﹤0.01%	759
2016 Q4	$63K	Buy	600 +200	+50%	+$20.9K	﹤0.01%	735
2016 Q3	$44K	Buy	400 +200	+100%	+$26.5K	﹤0.01%	765
2016 Q2	$29K	Buy	200 +100	+100%	+$14.2K	﹤0.01%	774
2016 Q1	$14K	Buy	+100	New	+$14.2K	﹤0.01%	811

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Commonwealth Bank of Australia's TARO Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 1,300 shares — an estimated $111K sold.

Commonwealth Bank of Australia first reported a position in TARO in Q1 2016 and held it in 11 quarters. The position peaked at $111K in Q2 2019. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 1,300 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $111K.
Commonwealth Bank of Australia first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 11 quarters.
Commonwealth Bank of Australia's Taro Pharmaceutical Industries Ltd. position peaked at $111K in Q2 2019.
101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.